PepGen Stock Craters 35% on FDA Clinical Hold

Seeking AlphaDec 16 09:56 ET

RBC Capital Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $35

Moomoo NewsDec 11 07:33 ET · Ratings

RBC Capital Sticks to Its Buy Rating for RegenXBio (RGNX)

TipRanksDec 11 06:39 ET · Ratings

Express News | Regenxbio Inc - to Offer and Sell Shares up to $150 Million

ReutersDec 9 16:48 ET

Express News | Regenxbio Inc - on Dec 9, Co Enters Sales Agreement With Leerink Partners

ReutersDec 9 16:48 ET

Apollo Global Management, Workday to Join S&P 500

MT NewswiresDec 9 06:31 ET